Dr. Leslie Discusses CAR T-Cell Therapy in MCL – OncLive
|
Dr. Leslie Discusses CAR T-Cell Therapy in MCL
OncLive Lori A. Leslie, MD, lymphoma attending, John Theurer Cancer Center, discusses the developing role of chimeric antigen receptor (CAR) T-cell therapy for patients with mantle cell lymphoma (MCL). CAR T-cell therapy is an exciting advancement across … |
